000 01484 a2200433 4500
005 20250517124226.0
264 0 _c20171218
008 201712s 0 0 eng d
022 _a1873-2763
024 7 _a10.1016/j.bone.2016.11.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVlot, Mariska C
245 0 0 _aEffect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
_h[electronic resource]
260 _bBone
_c02 2017
300 _a11-19 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aBone Density
650 0 4 _aBone Remodeling
650 0 4 _aFemale
650 0 4 _aFemur Neck
_xphysiopathology
650 0 4 _aGonadal Hormones
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLumbar Vertebrae
_xphysiopathology
650 0 4 _aMale
650 0 4 _aOsteocalcin
_xblood
650 0 4 _aPeptide Fragments
_xblood
650 0 4 _aProcollagen
_xblood
650 0 4 _aPuberty
650 0 4 _aTransgender Persons
700 1 _aKlink, Daniel T
700 1 _aden Heijer, Martin
700 1 _aBlankenstein, Marinus A
700 1 _aRotteveel, Joost
700 1 _aHeijboer, Annemieke C
773 0 _tBone
_gvol. 95
_gp. 11-19
856 4 0 _uhttps://doi.org/10.1016/j.bone.2016.11.008
_zAvailable from publisher's website
999 _c26604751
_d26604751